Re: Daniel M. Geynisman. Anti-programmed cell death protein 1 (PD-1) antibody nivolumab leads to a dramatic and rapid response in papillary renal cell carcinoma with sarcomatoid and rhabdoid features. Eur Urol 2015;68:912–4

M. Francesca Monn, Liang Cheng, Marina Scarpelli, Antonio Lopez-Beltran, Rodolfo Montironi

Research output: Contribution to journalLetter

Original languageEnglish (US)
Pages (from-to)e27-e28
JournalEuropean Urology
Issue number1
StatePublished - Jan 1 2017

ASJC Scopus subject areas

  • Urology

Cite this